A Phase I study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of AZD9898

Trial Identifier: D7620C00001
Sponsor: AstraZeneca
Collaborator:
PAREXEL
NCTID:: NCT03140072
Start Date: May 2017
Primary Completion Date: August 2017
Study Completion Date: August 2017
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United Kingdom Harrow, United Kingdom, HA1 3UJ
United Kingdom Manchester, United Kingdom, M23 9QZ